| Original language | English (US) |
|---|---|
| Pages (from-to) | 1312-1314 |
| Number of pages | 3 |
| Journal | Movement Disorders |
| Volume | 35 |
| Issue number | 8 |
| DOIs |
|
| State | Published - Aug 1 2020 |
| Externally published | Yes |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Movement Disorders, Vol. 35, No. 8, 01.08.2020, p. 1312-1314.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Stem Cells
T2 - Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease
AU - Jankovic, Joseph
AU - Okun, Michael S.
AU - Kordower, Jeffrey H.
N1 - Funding Information: Dr. Jankovic receives research/training grants from AbbVie Inc, F. Hoffmann‐La Roche Ltd, Medtronic Neuromodulation, Michael J. Fox Foundation for Parkinson Research, National Institutes of Health, Parkinson's Foundation, and Teva Pharmaceutical Industries Ltd. Dr. Jankovic is a consultant to Aeon BioPharma, Nuvelution Pharma, Inc, and Teva Pharmaceutical Industries Ltd. He has received royalties from Cambridge, Elsevier, Medlink: Neurology, Lippincott Williams and Wilkins, Wiley‐Blackwell. Dr. Okun serves as a consultant for the Parkinson's Foundation and has received research grants from the National Institutes of Health, Parkinson's Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann‐Strauss Foundation, the Tourette Syndrome Association, and the University of Florida Foundation. Dr. Okun's DBS research is supported by National Institutes of Health R01 NR014852 and R01NS096008. Dr. Okun is Principal Investigator (PI) of the National Institutes of Health R25NS108939 Training Grant. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford, and Cambridge (movement disorders books). Dr. Okun is an associate editor for . Dr. Okun has participated in CME and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD/Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society, and Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic, Abbvie, Boston Scientific, Abbott, and Allergan and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co‐investigator for several National Institutes of Health, foundation, and industry sponsored trials over the years, but has not received honoraria. Research projects at the University of Florida receive device and drug donations. Dr. Kordower serves as a consultant and scientific advisor to Fuji‐Cellular Dynamics, Inc. a company performing preclinical, and is in the planning stages of clinical induced pluripotent stem cells dopamine grafts in patients with Parkinson's disease. Dr. Kordower is also a consultant for Seelos, Inc., NsGene Inc, Brainstorm, Inc., Abbvie, Inc., Biogen, Inc., and Inhibikase, Inc. Dr. Kordower is also an associate editor for , , and . New England Journal of Medicine Journal Watch Neurology Journal of Comparative Neurology Neurobiology of Aging Journal of Parkinson's Disease
PY - 2020/8/1
Y1 - 2020/8/1
UR - http://www.scopus.com/inward/record.url?scp=85087644996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087644996&partnerID=8YFLogxK
U2 - 10.1002/mds.28187
DO - 10.1002/mds.28187
M3 - Comment/debate
C2 - 32529662
AN - SCOPUS:85087644996
SN - 0885-3185
VL - 35
SP - 1312
EP - 1314
JO - Movement Disorders
JF - Movement Disorders
IS - 8
ER -